About Us
Watson Pharmaceuticals, Inc. (NYSE: WPI) is a leading global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has approximately 6,000 employees and operations in many of the world’s established and emerging markets.
Our Strategic Focus
Since its founding as a U.S.-based generic pharmaceutical company in 1984, Watson has evolved to become one of today's most respected global specialty pharmaceutical companies.
Watson generates revenue through three key businesses - Brand, Generic and Distribution – with the majority of revenue stemming from generic product sales. The Company’s generic product line is among the broadest in the industry, with over 150 products. In the U.S., Watson is ranked fourth in the generic pharmaceutical marketplace in terms of number of prescriptions dispensed annually1. The Company also has approximately 27 brand pharmaceutical product families.